Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.906 |
High Similarity |
NPD2533 |
Approved |
0.906 |
High Similarity |
NPD2532 |
Approved |
0.906 |
High Similarity |
NPD2534 |
Approved |
0.8718 |
High Similarity |
NPD7819 |
Suspended |
0.8457 |
Intermediate Similarity |
NPD5710 |
Approved |
0.8457 |
Intermediate Similarity |
NPD5711 |
Approved |
0.8355 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8193 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.817 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8105 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8063 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8039 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8039 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8025 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7988 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7975 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7961 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7933 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7888 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD920 |
Approved |
0.7758 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7711 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7658 |
Intermediate Similarity |
NPD1243 |
Approved |
0.764 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD3750 |
Approved |
0.761 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7605 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.759 |
Intermediate Similarity |
NPD2801 |
Approved |
0.758 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7548 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD37 |
Approved |
0.7528 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4966 |
Approved |
0.75 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4965 |
Approved |
0.75 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7458 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7458 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7456 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7427 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD919 |
Approved |
0.7399 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7378 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7349 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD5402 |
Approved |
0.733 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7314 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7312 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7288 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD5408 |
Approved |
0.725 |
Intermediate Similarity |
NPD5405 |
Approved |
0.725 |
Intermediate Similarity |
NPD5404 |
Approved |
0.725 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7238 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7191 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7182 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD7240 |
Approved |
0.715 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7126 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7119 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD7644 |
Approved |
0.7108 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7107 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.71 |
Intermediate Similarity |
NPD8366 |
Approved |
0.7099 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7099 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7073 |
Intermediate Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7037 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7025 |
Intermediate Similarity |
NPD411 |
Approved |
0.7025 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7022 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD1281 |
Approved |
0.6979 |
Remote Similarity |
NPD7697 |
Approved |
0.6979 |
Remote Similarity |
NPD7698 |
Approved |
0.6979 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD17 |
Approved |
0.6974 |
Remote Similarity |
NPD4626 |
Approved |
0.6961 |
Remote Similarity |
NPD8491 |
Approved |
0.6948 |
Remote Similarity |
NPD9717 |
Approved |
0.6946 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD7874 |
Approved |
0.6939 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6936 |
Remote Similarity |
NPD4288 |
Approved |
0.6936 |
Remote Similarity |
NPD5353 |
Approved |
0.6933 |
Remote Similarity |
NPD2438 |
Suspended |
0.6933
|
Remote Similarity |
NPD7340 |
Approved |